NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00491491,Zevalin-beam for Aggressive Lymphoma,https://clinicaltrials.gov/study/NCT00491491,,COMPLETED,The study hypothesis is that the addition of zevalin radioimmunotherapy to the conditioning regimen given prior to BEAM high-dose chemotherapy and autologous stem cell transplantation in patients with aggressive lymphoma will reduced disease recurrence rate and improve overall and disease-free survival.,YES,Non-Hodgkin's Lymphoma,DRUG: ibritumomab tiuxetan|PROCEDURE: BEAM chemotherapy and autologous stem-cell transplantation,"Overall Survival, actuarial 2 year survival, 2 years after transplantation","Progression-free Survival, actuarial 2-year PFS, 2 years after transplantation|Clinical Response, complete response (CR) and partial response (PR) proportion at day 100,, 100 days after transplantation|Hematopoietic Recovery, time to hematopoietic recovery, 100 days after transplantation|Grade III Toxicity, incidence of infection, grade III-IV toxicities, treatment-related mortality, 100 days after transplantation|Secondary Malignancies, incidence of myelodysplastic syndrome (MDS), and secondary acute myelogenous leukemia (AML)., 5 years after transplantation",,Sheba Medical Center,"City of Hope Medical Center|Amsterdam UMC, location VUmc|University of Göttingen",ALL,"ADULT, OLDER_ADULT",PHASE3,60,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,SHEBA-07-4466-AN-CTIL,2007-06,2015-02,2015-02,2007-06-26,2020-08-31,2020-08-31,"Mayo Clinic Arizona, Scottsdale, Arizona, United States|City of Hope National Medical Center, Duarte, California, 91010-3000, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Moffitt Cancer Center, Tampa, Florida, United States|Northwestern University, Chicago, Illinois, United States|Mayo Clinic, Rochester, Minnesota, 55905, United States|Georg-August Universität, Göttingen, Germany|Chaim Sheba Medical Center, Tel Hashomer, Israel|VU Medical Center, Amsterdam, Netherlands",
